The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Aditya K. Gupta

Mediprobe Research Inc.

London

Canada

[email]@execulink.com

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Mediprobe Research Inc., London, Canada. 2012
  • Division of Dermatology, Department of Medicine, University of Toronto, Toronto. 1998 - 2012
  • Sunnybrook Health Science Center, Division of Dermatology, University of Toronto, Ontario, Canada. 1998 - 2005
  • University of Toronto, Toronto, Canada. 2000 - 2002
  • Department of Medicine, Sunnybrook Health Sciences Center and the University of Toronto, and the Ontario Ministry of Health, Laboratory Services Branch and Department of Laboratory Medicine and Pathology, University of Toronto. 1999

References

  1. Interventions for actinic keratoses. Gupta, A.K., Paquet, M., Villanueva, E., Brintnell, W. Cochrane. Database. Syst. Rev (2012) [Pubmed]
  2. New therapeutic options for onychomycosis. Gupta, A.K., Simpson, F.C. Expert. Opin. Pharmacother (2012) [Pubmed]
  3. The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis. Gupta, A.K., Lynch, L.E., Kogan, N., Cooper, E.A. J. Eur. Acad. Dermatol. Venereol (2009) [Pubmed]
  4. Psoriatic nail disease: quality of life and treatment. Gupta, A.K., Cooper, E.A. J. Cutan. Med. Surg (2009) [Pubmed]
  5. Meta-analysis: griseofulvin efficacy in the treatment of tinea capitis. Gupta, A.K., Cooper, E.A., Bowen, J.E. J. Drugs. Dermatol (2008) [Pubmed]
  6. Naftifine: a review. Gupta, A.K., Ryder, J.E., Cooper, E.A. J. Cutan. Med. Surg (2008) [Pubmed]
  7. Update in antifungal therapy of dermatophytosis. Gupta, A.K., Cooper, E.A. Mycopathologia (2008) [Pubmed]
  8. Position statement for isotretinoin. Gupta, A.K., Lynde, C.W., Poulin, Y., Smith, K., Lewis, R., Zip, C. J. Cutan. Med. Surg (2007) [Pubmed]
  9. Efalizumab in the treatment of psoriasis. Gupta, A.K., Cherman, A.M. J. Cutan. Med. Surg (2006) [Pubmed]
  10. Ciclopirox 1% shampoo for the treatment of seborrheic dermatitis. Gupta, A.K., Nicol, K.A. Int. J. Dermatol. (2006) [Pubmed]
  11. Dermatophytes: diagnosis and treatment. Gupta, A.K., Tu, L.Q. J. Am. Acad. Dermatol. (2006) [Pubmed]
  12. Diagnosing onychomycosis. Gupta, A.K., Ricci, M.J. Dermatol. Clin (2006) [Pubmed]
  13. Therapies for onychomycosis: a review. Gupta, A.K., Tu, L.Q. Dermatol. Clin (2006) [Pubmed]
  14. Onychomycosis therapies: strategies to improve efficacy. Gupta, A.K., Tu, L.Q. Dermatol. Clin (2006) [Pubmed]
  15. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus. Gupta, A.K., Gover, M.D., Lynde, C.W. J. Eur. Acad. Dermatol. Venereol (2006) [Pubmed]
  16. Pityriasis versicolor: a review of pharmacological treatment options. Gupta, A.K., Kogan, N., Batra, R. Expert. Opin. Pharmacother (2005) [Pubmed]
  17. In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species. Gupta, A.K., Kohli, Y., Batra, R. Med. Mycol. (2005) [Pubmed]
  18. Rosacea and its management: an overview. Gupta, A.K., Chaudhry, M.M. J. Eur. Acad. Dermatol. Venereol (2005) [Pubmed]
  19. The use of terbinafine in the treatment of onychomycosis in adults and special populations: a review of the evidence. Gupta, A.K., Ryder, J.E., Lynch, L.E., Tavakkol, A. J. Drugs. Dermatol (2005) [Pubmed]
  20. Evaluation of the efficacy of ciclopirox 0.77% gel in the treatment of tinea pedis interdigitalis (dermatophytosis complex) in a randomized, double-blind, placebo-controlled trial. Gupta, A.K., Skinner, A.R., Cooper, E.A. Int. J. Dermatol. (2005) [Pubmed]
  21. A phase I/II randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis. Gupta, A.K., Leonardi, C., Stoltz, R.R., Pierce, P.F., Conetta, B. J. Eur. Acad. Dermatol. Venereol (2005) [Pubmed]
  22. Ciclopirox topical solution, 8% combined with oral terbinafine to treat onychomycosis: a randomized, evaluator-blinded study. Gupta, A.K. J. Drugs. Dermatol (2005) [Pubmed]
  23. Dermatophytosis: the management of fungal infections. Gupta, A.K., Ryder, J.E., Chow, M., Cooper, E.A. Skinmed (2005) [Pubmed]
  24. Seborrheic dermatitis. Gupta, A.K., Bluhm, R. J. Eur. Acad. Dermatol. Venereol (2004) [Pubmed]
  25. Pityriasis versicolor: quality of studies. Gupta, A.K., Nicol, K., Johnson, A. J. Dermatolog. Treat (2004) [Pubmed]
  26. Onychomycosis in children: a brief overview with treatment strategies. Gupta, A.K., Skinner, A.R. Pediatr. Dermatol (2004) [Pubmed]
  27. Onychomycosis: classification and diagnosis. Gupta, A.K., Ryder, J.E., Summerbell, R.C. J. Drugs. Dermatol (2004) [Pubmed]
  28. Prevalence of Malassezia species on various body sites in clinically healthy subjects representing different age groups. Gupta, A.K., Kohli, Y. Med. Mycol. (2004) [Pubmed]
  29. Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis. Gupta, A.K., Ryder, J.E., Johnson, A.M. Br. J. Dermatol. (2004) [Pubmed]
  30. Seborrheic dermatitis of the scalp: etiology and treatment. Gupta, A.K., Nicol, K.A. J. Drugs. Dermatol (2004) [Pubmed]
  31. Seborrhoeic dermatitis: current treatment practices. Gupta, A.K., Kogan, N. Expert. Opin. Pharmacother (2004) [Pubmed]
  32. Ciclopirox: a broad-spectrum antifungal with antibacterial and anti-inflammatory properties. Gupta, A.K., Plott, T. Int. J. Dermatol. (2004) [Pubmed]
  33. Optimal management of fungal infections of the skin, hair, and nails. Gupta, A.K., Cooper, E.A., Ryder, J.E., Nicol, K.A., Chow, M., Chaudhry, M.M. Am. J. Clin. Dermatol (2004) [Pubmed]
  34. The use of sulfur in dermatology. Gupta, A.K., Nicol, K. J. Drugs. Dermatol (2004) [Pubmed]
  35. Skin diseases associated with Malassezia species. Gupta, A.K., Batra, R., Bluhm, R., Boekhout, T., Dawson, T.L. J. Am. Acad. Dermatol. (2004) [Pubmed]
  36. Management of diaper dermatitis. Gupta, A.K., Skinner, A.R. Int. J. Dermatol. (2004) [Pubmed]
  37. Prednicarbate (dermatop): a review. Gupta, A.K., Chow, M. J. Drugs. Dermatol (2004) [Pubmed]
  38. Role of antifungal agents in the treatment of seborrheic dermatitis. Gupta, A.K., Nicol, K., Batra, R. Am. J. Clin. Dermatol (2004) [Pubmed]
  39. A review of the use of infliximab to manage cutaneous dermatoses. Gupta, A.K., Skinner, A.R. J. Cutan. Med. Surg (2004) [Pubmed]
  40. Treatment of onychomycosis: pros and cons of antifungal agents. Gupta, A.K., Ryder, J.E., Skinner, A.R. J. Cutan. Med. Surg (2004) [Pubmed]
  41. Prescribing practices for seborrheic dermatitis vary with the physician's specialty: implications for clinical practice. Gupta, A.K., Bluhm, R., Barlow, J.O., Fleischer, A.B., Feldman, S.R. J. Dermatolog. Treat (2004) [Pubmed]
  42. Viral and nonviral uses of imiquimod: a review. Gupta, A.K., Cherman, A.M., Tyring, S.K. J. Cutan. Med. Surg (2004) [Pubmed]
  43. Prednicarbate (Dermatop): profile of a corticosteroid. Gupta, A.K., Chow, M. J. Cutan. Med. Surg (2004) [Pubmed]
  44. A randomized, double-blind, multicenter, parallel group study to compare relative efficacies of the topical gels 3% erythromycin/5% benzoyl peroxide and 0.025% tretinoin/erythromycin 4% in the treatment of moderate acne vulgaris of the face. Gupta, A.K., Lynde, C.W., Kunynetz, R.A., Amin, S., Choi, K., Goldstein, E. J. Cutan. Med. Surg (2003) [Pubmed]
  45. The diagnosis of nondermatophyte mold onychomycosis. Gupta, A.K., Ryder, J.E., Summerbell, R.C. Int. J. Dermatol. (2003) [Pubmed]
  46. Comparison of efficacy criteria across onychomycosis trials: need for standardization. Gupta, A.K., Ryder, J., Summerbell, R.C. Int. J. Dermatol. (2003) [Pubmed]
  47. Non-dermatophyte onychomycosis. Gupta, A.K., Ryder, J.E., Baran, R., Summerbell, R.C. Dermatol. Clin (2003) [Pubmed]
  48. Onychomycosis in children: an overview. Gupta, A.K., Skinner, A.R., Baran, R. J. Drugs. Dermatol (2003) [Pubmed]
  49. Onychomycosis: quality of studies. Gupta, A.K., Ryder, J.E., Bluhm, R., Johnson, A., Summerbell, R.C. J. Cutan. Med. Surg (2003) [Pubmed]
  50. Ciclopirox gel: an update. Gupta, A.K. Int. J. Dermatol. (2003) [Pubmed]
  51. Ciclopirox for the treatment of superficial fungal infections: a review. Gupta, A.K., Skinner, A.R. Int. J. Dermatol. (2003) [Pubmed]
  52. Interdigital tinea pedis (dermatophytosis simplex and complex) and treatment with ciclopirox 0.77% gel. Gupta, A.K., Skinner, A.R., Cooper, E.A. Int. J. Dermatol. (2003) [Pubmed]
  53. Evaluating the quality of rosacea studies: implications for the patient and physician. Gupta, A.K., Chaudhry, M.M. Dermatology. (Basel) (2003) [Pubmed]
  54. Analysis of factors associated with increased prescription illegibility: results from the National Ambulatory Medical Care Survey, 1990-1998. Gupta, A.K., Cooper, E.A., Feldman, S.R., Fleischer, A.B., Balkrishnan, R. Am. J. Manag. Care (2003) [Pubmed]
  55. Pimecrolimus: a review. Gupta, A.K., Chow, M. J. Eur. Acad. Dermatol. Venereol (2003) [Pubmed]
  56. Arthroconidial formation in Trichophyton raubitschekii. Gupta, A.K., Ahmad, I., Porretta, M., Summerbell, R.C. Mycoses (2003) [Pubmed]
  57. Tinea corporis, tinea cruris, tinea nigra, and piedra. Gupta, A.K., Chaudhry, M., Elewski, B. Dermatol. Clin (2003) [Pubmed]
  58. Seborrheic dermatitis. Gupta, A.K., Bluhm, R., Cooper, E.A., Summerbell, R.C., Batra, R. Dermatol. Clin (2003) [Pubmed]
  59. Pityriasis versicolor. Gupta, A.K., Batra, R., Bluhm, R., Faergemann, J. Dermatol. Clin (2003) [Pubmed]
  60. Treatments of tinea pedis. Gupta, A.K., Chow, M., Daniel, C.R., Aly, R. Dermatol. Clin (2003) [Pubmed]
  61. The use of oral antifungal agents to treat onychomycosis. Gupta, A.K., Ryder, J.E. Dermatol. Clin (2003) [Pubmed]
  62. The use of topical therapies to treat onychomycosis. Gupta, A.K., Ryder, J.E., Baran, R. Dermatol. Clin (2003) [Pubmed]
  63. How to improve cure rates for the management of onychomycosis. Gupta, A.K., Ryder, J.E. Dermatol. Clin (2003) [Pubmed]
  64. The efficacy and safety of terbinafine in children. Gupta, A.K., Cooper, E.A., Lynde, C.W. Dermatol. Clin (2003) [Pubmed]
  65. Efficacy and safety of itraconazole use in children. Gupta, A.K., Cooper, E.A., Ginter, G. Dermatol. Clin (2003) [Pubmed]
  66. The use of fluconazole to treat superficial fungal infections in children. Gupta, A.K., Cooper, E.A., Montero-Gei, F. Dermatol. Clin (2003) [Pubmed]
  67. New antifungal agents. Gupta, A.K., Tomas, E. Dermatol. Clin (2003) [Pubmed]
  68. Photodynamic therapy and topical aminolevulinic acid: an overview. Gupta, A.K., Ryder, J.E. Am. J. Clin. Dermatol (2003) [Pubmed]
  69. Critical review of the manner in which the efficacy of therapies for rosacea are evaluated. Gupta, A.K., Chaudhry, M.M. Int. J. Dermatol. (2003) [Pubmed]
  70. Evaluation of in vitro resistance in patients with onychomycosis who fail antifungal therapy. Gupta, A.K., Kohli, Y. Dermatology. (Basel) (2003) [Pubmed]
  71. Superficial fungal infections: an update on pityriasis versicolor, seborrheic dermatitis, tinea capitis, and onychomycosis. Gupta, A.K., Ryder, J.E., Nicol, K., Cooper, E.A. Clin. Dermatol. (2003) [Pubmed]
  72. The efficacy and safety of terbinafine in children. Gupta, A.K., Adamiak, A., Cooper, E.A. J. Eur. Acad. Dermatol. Venereol (2003) [Pubmed]
  73. Hepatic safety of itraconazole. Gupta, A.K., Chwetzoff, E., Del Rosso, J., Baran, R. J. Cutan. Med. Surg (2002) [Pubmed]
  74. Pityriasis versicolor. Gupta, A.K., Bluhm, R., Summerbell, R. J. Eur. Acad. Dermatol. Venereol (2002) [Pubmed]
  75. Tacrolimus: a review of its use for the management of dermatoses. Gupta, A.K., Adamiak, A., Chow, M. J. Eur. Acad. Dermatol. Venereol (2002) [Pubmed]
  76. Fungicidal activities of commonly used disinfectants and antifungal pharmaceutical spray preparations against clinical strains of Aspergillus and Candida species. Gupta, A.K., Ahmad, I., Summerbell, R.C. Med. Mycol. (2002) [Pubmed]
  77. Nonpsoriatic uses of calcipotriol. Gupta, A.K., Browne, M., Bluhm, R. J. Cutan. Med. Surg (2002) [Pubmed]
  78. Imiquimod: a review. Gupta, A.K., Browne, M., Bluhm, R. J. Cutan. Med. Surg (2002) [Pubmed]
  79. Management of toe onychomycosis: what is the potential for improving efficacy of treatment?. Gupta, A.K. Clin. Dermatol. (2002) [Pubmed]
  80. Alternate week and combination itraconazole and terbinafine therapy for chromoblastomycosis caused by Fonsecaea pedrosoi in Brazil. Gupta, A.K., Taborda, P.R., Sanzovo, A.D. Med. Mycol. (2002) [Pubmed]
  81. Onychomycosis: strategies to improve efficacy and reduce recurrence. Gupta, A.K., Baran, R., Summerbell, R. J. Eur. Acad. Dermatol. Venereol (2002) [Pubmed]
  82. Update on the safety of itraconazole pulse therapy in onychomycosis and dermatomycoses. Gupta, A., Lambert, J., Revuz, J., Shear, N. Eur. J. Dermatol (2001) [Pubmed]
  83. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly. Gupta, A.K., Konnikov, N., Lynde, C.W. J. Am. Acad. Dermatol. (2001) [Pubmed]
  84. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis. Gupta, A.K., Lynde, C.W., Konnikov, N. J. Am. Acad. Dermatol. (2001) [Pubmed]
  85. Epidemiology of Malassezia yeasts associated with pityriasis versicolor in Ontario, Canada. Gupta, A.K., Kohli, Y., Faergemann, J., Summerbell, R.C. Med. Mycol. (2001) [Pubmed]
  86. Utility of inoculum counting (Walshe and English criteria) in clinical diagnosis of onychomycosis caused by nondermatophytic filamentous fungi. Gupta, A.K., Cooper, E.A., MacDonald, P., Summerbell, R.C. J. Clin. Microbiol. (2001) [Pubmed]
  87. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes. Gupta, A.K., Gregurek-Novak, T. Dermatology. (Basel) (2001) [Pubmed]
  88. Quantitative culture of Malassezia species from different body sites of individuals with or without dermatoses. Gupta, A.K., Kohli, Y., Summerbell, R.C., Faergemann, J. Med. Mycol. (2001) [Pubmed]
  89. Variation in restriction fragment length polymorphisms among serial isolates from patients with Trichophyton rubrum infection. Gupta, A.K., Kohli, Y., Summerbell, R.C. J. Clin. Microbiol. (2001) [Pubmed]
  90. Ciclopirox: an overview. Gupta, A.K. Int. J. Dermatol. (2001) [Pubmed]
  91. Comparative efficacies of commonly used disinfectants and antifungal pharmaceutical spray preparations against dermatophytic fungi. Gupta, A.K., Ahmad, I., Summerbell, R.C. Med. Mycol. (2001) [Pubmed]
  92. Itraconazole and terbinafine treatment of some nondermatophyte molds causing onychomycosis of the toes and a review of the literature. Gupta, A.K., Gregurek-Novak, T., Konnikov, N., Lynde, C.W., Hofstader, S., Summerbell, R.C. J. Cutan. Med. Surg (2001) [Pubmed]
  93. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole. Gupta, A.K., Adam, P., Dlova, N., Lynde, C.W., Hofstader, S., Morar, N., Aboobaker, J., Summerbell, R.C. Pediatr. Dermatol (2001) [Pubmed]
  94. Itraconazole is effective in the treatment of tinea capitis caused by Microsporum canis. Gupta, A.K., Ginter, G. Pediatr. Dermatol (2001) [Pubmed]
  95. A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis. Gupta, A.K., Shear, N.H. Drug. Saf (2000) [Pubmed]
  96. Open-label study to evaluate the healing rate and safety of the Profore Extra Four-Layer Bandage System in patients with venous leg ulceration. Gupta, A.K., Koven, J.D., Lester, R., Shear, N.H., Sauder, D.N. J. Cutan. Med. Surg (2000) [Pubmed]
  97. Molecular differentiation of seven Malassezia species. Gupta, A.K., Kohli, Y., Summerbell, R.C. J. Clin. Microbiol. (2000) [Pubmed]
  98. In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine. Gupta, A.K., Kohli, Y., Li, A., Faergemann, J., Summerbell, R.C. Br. J. Dermatol. (2000) [Pubmed]
  99. Once weekly fluconazole is effective in children in the treatment of tinea capitis: a prospective, multicentre study. Gupta, A.K., Dlova, N., Taborda, P., Morar, N., Taborda, V., Lynde, C.W., Konnikov, N., Borges, M., Raboobee, N., Summerbell, R.C., Adam, P., Hofstader, S.L., Aboobaker, J. Br. J. Dermatol. (2000) [Pubmed]
  100. The prevalence and management of onychomycosis in diabetic patients. Gupta, A.K., Humke, S. Eur. J. Dermatol (2000) [Pubmed]
  101. Onychomycosis in the elderly. Gupta, A.K. Drugs. Aging (2000) [Pubmed]
  102. An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents. Gupta, A.K., Del Rosso, J.Q. Int. J. Dermatol. (2000) [Pubmed]
  103. Tinea capitis. Gupta, A.K., Summerbell, R.C. Med. Mycol. (2000) [Pubmed]
  104. Detection of xanthomegnin in epidermal materials infected with Trichophyton rubrum. Gupta, A.K., Ahmad, I., Borst, I., Summerbell, R.C. J. Invest. Dermatol. (2000) [Pubmed]
  105. Epidemiology and prevalence of onychomycosis in HIV-positive individuals. Gupta, A.K., Taborda, P., Taborda, V., Gilmour, J., Rachlis, A., Salit, I., Gupta, M.A., MacDonald, P., Cooper, E.A., Summerbell, R.C. Int. J. Dermatol. (2000) [Pubmed]
  106. Ciclopirox 8% nail lacquer in the treatment of onychomycosis of the toenails in the United States. Gupta, A.K., Joseph, W.S. J. Am. Podiatr. Med. Assoc (2000) [Pubmed]
  107. Ciclopirox nail lacquer and podiatric practice. Gupta, A.K., Malkin, K.F. J. Am. Podiatr. Med. Assoc (2000) [Pubmed]
  108. The epidemiology of onychomycosis: possible role of smoking and peripheral arterial disease. Gupta, A.K., Gupta, M.A., Summerbell, R.C., Cooper, E.A., Konnikov, N., Albreski, D., MacDonald, P., Harris, K.A. J. Eur. Acad. Dermatol. Venereol (2000) [Pubmed]
  109. Tinea capitis: an overview with emphasis on management. Gupta, A.K., Hofstader, S.L., Adam, P., Summerbell, R.C. Pediatr. Dermatol (1999) [Pubmed]
  110. Drug interactions with itraconazole, fluconazole, and terbinafine and their management. Gupta, A.K., Katz, H.I., Shear, N.H. J. Am. Acad. Dermatol. (1999) [Pubmed]
  111. Intermittent short duration therapy with fluconazole is effective for tinea capitis. Gupta, A.K., Adam, P., Hofstader, S.L., Lynde, C.W., Taborda, P., Taborda, V., Morar, N., Dlova, N., Raboobee, N., Konnikov, N., Aboobaker, J., Summerbell, R.C. Br. J. Dermatol. (1999) [Pubmed]
  112. Management of onychomycosis in children. Gupta, A.K., De Rosso, J.Q. Postgrad. Med (1999) [Pubmed]
  113. Itraconazole oral solution for the treatment of tinea capitis using the pulse regimen. Gupta, A.K., Adam, P., Soloman, R., Aly, R. Cutis (1999) [Pubmed]
  114. Pharmacoeconomic analysis of the new oral antifungal agents used to treat toenail onychomycosis in the USA. Gupta, A.K., Lambert, J. Int. J. Dermatol. (1999) [Pubmed]
  115. The new oral antifungal agents for onychomycosis of the toenails. Gupta, A.K., Shear, N.H. J. Eur. Acad. Dermatol. Venereol (1999) [Pubmed]
  116. Combined distal and lateral subungual and white superficial onychomycosis in the toenails. Gupta, A.K., Summerbell, R.C. J. Am. Acad. Dermatol. (1999) [Pubmed]
  117. The use of itraconazole to treat cutaneous fungal infections in children. Gupta, A.K., Nolting, S., de Prost, Y., Delescluse, J., Degreef, H., Theissen, U., Wallace, R., Marynissen, G., De Doncker, P. Dermatology. (Basel) (1999) [Pubmed]
  118. Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis. Gupta, A.K. Pharmacoeconomics (1998) [Pubmed]
  119. An overview of topical antifungal therapy in dermatomycoses. A North American perspective. Gupta, A.K., Einarson, T.R., Summerbell, R.C., Shear, N.H. Drugs (1998) [Pubmed]
  120. A questionnaire study on the management of onychomycosis: a Canadian perspective. Gupta, A.K., Shear, N.H. Int. J. Dermatol. (1998) [Pubmed]
  121. Onychomycosis associated with Onychocola canadensis: ten case reports and a review of the literature. Gupta, A.K., Horgan-Bell, C.B., Summerbell, R.C. J. Am. Acad. Dermatol. (1998) [Pubmed]
  122. Itraconazole oral solution for the treatment of tinea capitis. Gupta, A.K., Solomon, R.S., Adam, P. Br. J. Dermatol. (1998) [Pubmed]
  123. Increased incidence of Trichophyton tonsurans tinea capitis in Ontario, Canada between 1985 and 1996. Gupta, A.K., Summerbell, R.C. Med. Mycol. (1998) [Pubmed]
  124. Onychomycosis: strategies to reduce failure and recurrence. Gupta, A.K., Daniel, C.R. Cutis (1998) [Pubmed]
  125. Factors that may affect the response of onychomycosis to oral antifungal therapy. Gupta, A.K., Daniel, C.R. Australas. J. Dermatol. (1998) [Pubmed]
  126. Itraconazole pulse therapy is effective in the treatment of Majocchi's granuloma: a clinical and pharmacokinetic evaluation and implications for possible effectiveness in tinea capitis. Gupta, A.K., Groen, K., Woestenborghs, R., De Doncker, P. Clin. Exp. Dermatol. (1998) [Pubmed]
  127. Fluconazole for the treatment of onychomycosis: an update. Gupta, A.K., Scher, R.K., Rich, P. Int. J. Dermatol. (1998) [Pubmed]
  128. Onychomycosis in children: prevalence and management. Gupta, A.K., Chang, P., Del Rosso, J.Q., Adam, P., Hofstader, S.L. Pediatr. Dermatol (1998) [Pubmed]
  129. Itraconazole oral solution for the treatment of onychomycosis. Gupta, A.K., Adam, P., Hofstader, S.L. Pediatr. Dermatol (1998) [Pubmed]
  130. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey. Gupta, A.K., Konnikov, N., MacDonald, P., Rich, P., Rodger, N.W., Edmonds, M.W., McManus, R., Summerbell, R.C. Br. J. Dermatol. (1998) [Pubmed]
 
WikiGenes - Universities